Lack of CD8 <sup>+</sup> T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancerBrendan Horton, Stefani Spranger|Science Immunology|2021Cited by 127
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2Brendan Horton, Stefani Spranger, Maria Zagorulya et al.|JCI Insight|2023Cited by 25